BeiGene, Ltd. (ONC) — Cash Flow Reinvestment Rate

Latest as of March 2026: 0.20x

BeiGene, Ltd. (ONC) has a Cash Flow Reinvestment Rate of 0.20x as of March 2026, reinvesting $40.94 Million (capex $40.91 Million plus investments $27.00K) from operating cash flow of $201.94 Million. Check cash flow quality index of BeiGene, Ltd. to evaluate the quality of earnings relative to operating cash generation.

Reinvestment Rate

0.20x
(Capex + Investments) / Operating CF

Total Reinvested

$40.94 Million
Capex + Investments

Operating Cash Flow

$201.94 Million
USD

Capital Expenditures

$40.91 Million
USD

BeiGene, Ltd. Cash Flow Reinvestment Rate (2013–2025)

Historical reinvestment intensity for BeiGene, Ltd. across 3 annual periods. Explore BeiGene, Ltd. long-term investment allocation to see how much of total assets are deployed in long-term investments.

Annual Cash Flow Reinvestment Rate for BeiGene, Ltd. (2013–2025)

Year-by-year capital reinvestment analysis for BeiGene, Ltd.. For live market cap and broader valuation context, see BeiGene, Ltd. (ONC) total market value.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2025 0.17x $194.23 Million $1.13 Billion $185.84 Million ▼ -96.3%
2017 4.61x $58.73 Million $12.75 Million $58.73 Million ▲ +7005.2%
2013 0.06x $264.00K $4.07 Million $264.00K
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow